{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:33:41Z","timestamp":1789947221666,"version":"4.0.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.cellimm.2012.07.003","type":"journal-article","created":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T16:15:48Z","timestamp":1343837748000},"page":"91-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia"],"prefix":"10.1016","volume":"278","author":[{"given":"Sebastiano","family":"Gangemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Allegra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Alonci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Petrungaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Saitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrio","family":"Gerace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppa","family":"Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Musolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2012.07.003_b0005","doi-asserted-by":"crossref","first-page":"16651","DOI":"10.1074\/jbc.M109.071191","article-title":"Activation of JAK2\u2013V617F by components of heterodimeric cytokine receptors","volume":"285","author":"Pradhan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2012.07.003_b0010","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1158\/0008-5472.CAN-10-4002","article-title":"Bone marrow stroma-secreted cytokines protect JAK2(V617F)-mutated cells from the effects of a JAK2 inhibitor","volume":"71","author":"Manshouri","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2012.07.003_b0015","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1182\/blood-2011-06-363408","article-title":"Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigen","volume":"118","author":"Betts","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2012.07.003_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molimm.2008.12.019","article-title":"Properties and origin of human Th17 cells","volume":"47","author":"Romagnani","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2012.07.003_b0025","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2012.07.003_b0030","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2567.2011.03471.x","article-title":"Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1","author":"Brunsing","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.cellimm.2012.07.003_b0035","article-title":"Interleukin-23 receptor polymorphism as a risk factor for oral cancer susceptibility","author":"Chien","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.cellimm.2012.07.003_b0040","unstructured":"S. Gangemi, A. Allegra, A. Alonci, E. Pace, A. Cannav\u00f2, M. Ferraro, G. Penna, S. Saitta, D. Gerace, C. Musolino, Interleukin 22 is increased and correlated with CD38 expression in patients with B-Chronic Lymphocytic Leukemia, Blood Cell Mol. Dis., in press."},{"key":"10.1016\/j.cellimm.2012.07.003_b0045","article-title":"Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients","author":"Musolino","year":"2011","journal-title":"Acta Oncol."},{"key":"10.1016\/j.cellimm.2012.07.003_b0050","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1002\/jcp.22653","article-title":"Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: preliminary data and future perspectives","volume":"226","author":"Adamo","year":"2011","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.cellimm.2012.07.003_b0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5603\/FHC.2011.0022","article-title":"Evaluation of monocyte-derived dendritic cells T regulatory and Th17 cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors","volume":"49","author":"Hus","year":"2011","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.cellimm.2012.07.003_b0060","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/jir.2010.0083","article-title":"Interleukin-23-induced interleukin-23 receptor inpathway in human CD4 T cells","volume":"31","author":"Che Mat","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.cellimm.2012.07.003_b0065","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1172\/JCI31537","article-title":"A cytokine-mediated link between innate immunity, inflammation, and cancer","volume":"117","author":"Lin","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2012.07.003_b0070","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1084\/jem.20090207","article-title":"IL-17 can promote tumor growth through an IL-6\u2013Stat3 signaling pathway","volume":"206","author":"Wang","year":"2009","journal-title":"JEM"},{"key":"10.1016\/j.cellimm.2012.07.003_b0075","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3324\/haematol.2009.007047","article-title":"The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera","volume":"94","author":"Pieri","year":"2009","journal-title":"Haematologica"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874912001529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874912001529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:49:20Z","timestamp":1757803760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874912001529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":15,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0008874912001529"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2012.07.003","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2012.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}